Hossein Arefanian

Kuwait City, KU, Kuwait

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications

Sucrose-free low-fat diet induces metabolic dysfunction through gut dysbiosis and colonic inflammation in mice.

Sucrose-free low-fat diet induces metabolic dysfunction through gut dysbiosis and colonic inflammation in mice.

Journal: Frontiers in immunology
Published: February 19, 2026

Unraveling the RKIP-YY1 axis: immune crosstalk in the pathogenesis of metabolic disorders.

Unraveling the RKIP-YY1 axis: immune crosstalk in the pathogenesis of metabolic disorders.

Journal: Frontiers in immunology
Published: July 29, 2025

Verapamil Restores β-Cell Mass and Function in Diabetogenic Stress Models via Proliferation and Mitochondrial Respiration.

Verapamil Restores β-Cell Mass and Function in Diabetogenic Stress Models via Proliferation and Mitochondrial Respiration.

Journal: Cells
Published: July 28, 2025

IL-1β-Induced CXCL10 Expression in THP-1 Monocytic Cells Involves the JNK/c-Jun and NF-κB-Mediated Signaling.

IL-1β-Induced CXCL10 Expression in THP-1 Monocytic Cells Involves the JNK/c-Jun and NF-κB-Mediated Signaling.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 29, 2024

Gut Dysbiosis Shaped by Cocoa Butter-Based Sucrose-Free HFD Leads to Steatohepatitis, and Insulin Resistance in Mice.

Gut Dysbiosis Shaped by Cocoa Butter-Based Sucrose-Free HFD Leads to Steatohepatitis, and Insulin Resistance in Mice.

Journal: Nutrients
Published: April 15, 2024

Unraveling Verapamil's Multidimensional Role in Diabetes Therapy: From β-Cell Regeneration to Cholecystokinin Induction in Zebrafish and MIN6 Cell-Line Models.

Unraveling Verapamil's Multidimensional Role in Diabetes Therapy: From β-Cell Regeneration to Cholecystokinin Induction in Zebrafish and MIN6 Cell-Line Models.

Journal: Cells
Published: March 27, 2024

Soybean oil-based HFD induces gut dysbiosis that leads to steatosis, hepatic inflammation and insulin resistance in mice.

Soybean oil-based HFD induces gut dysbiosis that leads to steatosis, hepatic inflammation and insulin resistance in mice.

Journal: Frontiers in microbiology
Published: March 26, 2024

Comparative efficacy, toxicity, and insulin-suppressive effects of simvastatin and pravastatin in fatty acid-challenged mouse insulinoma MIN6 β-cell model.

Comparative efficacy, toxicity, and insulin-suppressive effects of simvastatin and pravastatin in fatty acid-challenged mouse insulinoma MIN6 β-cell model.

Journal: Frontiers in endocrinology
Published: February 07, 2024

Neutral Sphingomyelinase 2 Inhibition Limits Hepatic Steatosis and Inflammation.

Neutral Sphingomyelinase 2 Inhibition Limits Hepatic Steatosis and Inflammation.

Journal: Cells
Published: January 24, 2024

Effect of Dual Glucagon-Like Peptide 1/Glucose-Dependent Insulinotropic Polypeptide Receptor Agonist (Tirzepatide) versus Bariatric Surgery on Weight Loss and Nonalcoholic Fatty Liver Disease.

Effect of Dual Glucagon-Like Peptide 1/Glucose-Dependent Insulinotropic Polypeptide Receptor Agonist (Tirzepatide) versus Bariatric Surgery on Weight Loss and Nonalcoholic Fatty Liver Disease.

Journal: Medical principles and practice : international journal of the Kuwait University, Health Science Centre
Published: December 31, 2023

Verapamil chronicles: advances from cardiovascular to pancreatic β-cell protection.

Verapamil chronicles: advances from cardiovascular to pancreatic β-cell protection.

Journal: Frontiers in pharmacology
Published: October 15, 2023

Differential effects of fish-oil and cocoa-butter based high-fat/high-sucrose diets on endocrine pancreas morphology and function in mice.

Differential effects of fish-oil and cocoa-butter based high-fat/high-sucrose diets on endocrine pancreas morphology and function in mice.

Journal: Frontiers in endocrinology
Published: July 23, 2023
Showing 1-12 of 45

Last Updated: 09/26/2026